651 followers
RT @Myeloma_Doc: Mapatumumab (agonistic anti-TRAIL-R1) & #Velcade induce potent NK cell-dependent anti-#myeloma cytotoxic T cells: http://t…
RT @Myeloma_Doc: Mapatumumab (agonistic anti-TRAIL-R1) & #Velcade induce potent NK cell-dependent anti-#myeloma cytotoxic T cells: http://t…
potent NK cell-dependent anti-myeloma cytotoxic T cells combined mapatumumab and bortezomib. - PubMed - NCBI http://t.co/NFUld8I9Tj
RT @Myeloma_Doc: Mapatumumab (agonistic anti-TRAIL-R1) & #Velcade induce potent NK cell-dependent anti-#myeloma cytotoxic T cells: http://t…
RT @Myeloma_Doc: Mapatumumab (agonistic anti-TRAIL-R1) & #Velcade induce potent NK cell-dependent anti-#myeloma cytotoxic T cells: http://t…